71 related articles for article (PubMed ID: 20505335)
1. TargetScreen: an unbiased approach to identify functionally important microRNA targets.
Mavrakis KJ; Wendel HG
Cell Cycle; 2010 Jun; 9(11):2080-4. PubMed ID: 20505335
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
Mavrakis KJ; Wolfe AL; Oricchio E; Palomero T; de Keersmaecker K; McJunkin K; Zuber J; James T; Khan AA; Leslie CS; Parker JS; Paddison PJ; Tam W; Ferrando A; Wendel HG
Nat Cell Biol; 2010 Apr; 12(4):372-9. PubMed ID: 20190740
[TBL] [Abstract][Full Text] [Related]
3.
Zhou JD; Li XX; Zhang TJ; Xu ZJ; Zhang ZH; Gu Y; Wen XM; Zhang W; Ji RB; Deng ZQ; Lin J; Qian J
Aging (Albany NY); 2019 May; 11(10):3376-3391. PubMed ID: 31147526
[No Abstract] [Full Text] [Related]
4. miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.
Mutlu M; Saatci Ö; Ansari SA; Yurdusev E; Shehwana H; Konu Ö; Raza U; Şahin Ö
Sci Rep; 2016 Sep; 6():32541. PubMed ID: 27600857
[TBL] [Abstract][Full Text] [Related]
5. The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling.
Catanzaro G; Besharat ZM; Miele E; Chiacchiarini M; Po A; Carai A; Marras CE; Antonelli M; Badiali M; Raso A; Mascelli S; Schrimpf D; Stichel D; Tartaglia M; Capper D; von Deimling A; Giangaspero F; Mastronuzzi A; Locatelli F; Ferretti E
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):687-706. PubMed ID: 29478280
[TBL] [Abstract][Full Text] [Related]
6. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
9. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Ishibashi O; Akagi I; Ogawa Y; Inui T
Biochem Biophys Res Commun; 2018 Jun; 501(2):507-513. PubMed ID: 29738771
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-7 inhibits cell proliferation of chronic myeloid leukemia and sensitizes it to imatinib in vitro.
Jiang MJ; Dai JJ; Gu DN; Huang Q; Tian L
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):372-378. PubMed ID: 28986256
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
12. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
14. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
Noguchi S; Yasui Y; Iwasaki J; Kumazaki M; Yamada N; Naito S; Akao Y
Cancer Lett; 2013 Jan; 328(2):353-61. PubMed ID: 23104321
[TBL] [Abstract][Full Text] [Related]
15. miR-17∼92 in lymphocyte development and lymphomagenesis.
Labi V; Schoeler K; Melamed D
Cancer Lett; 2019 Apr; 446():73-80. PubMed ID: 30660648
[TBL] [Abstract][Full Text] [Related]
16. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
[TBL] [Abstract][Full Text] [Related]
17. Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy.
Mishra PJ; Mishra PJ; Merlino G
PLoS One; 2016; 11(11):e0165102. PubMed ID: 27846237
[TBL] [Abstract][Full Text] [Related]
18. miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways.
Fang ZH; Wang SL; Zhao JT; Lin ZJ; Chen LY; Su R; Xie ST; Carter BZ; Xu B
Cell Death Dis; 2016 Sep; 7(9):e2371. PubMed ID: 27899822
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic microRNAs in the genesis of leukemia and lymphoma.
Pan Y; Meng M; Zhang G; Han H; Zhou Q
Curr Pharm Des; 2014; 20(33):5260-7. PubMed ID: 24479800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
